No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ALC240517P62500
- 0.85
- 0.000.00%
15min DelayTrading Jan 23 09:30 ET
0.00High0.00Low
0.00Open0.85Pre Close0 Volume23 Open Interest62.50Strike Price0.00Turnover144.94%IV-24.36%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier8DDays to Expiry0.85Time Value100Contract SizeAmericanOptions Type-0.0925Delta0.0092Gamma95.89Leverage Ratio-0.1730Theta-0.0018Rho-8.87Eff Leverage0.0205Vega
Intraday
- 5D
- 1D
News
Alcon's Solid Performance and Growth Momentum Justify Buy Rating Despite FX Headwinds
Alcon's Growth Trajectory: Positive Survey Insights and Product Launches Drive Buy Rating
Express News | Sight Sciences Shares Are Trading Higher After the Company Announced a $34 Million Patent Infringement Verdict Against Alcon and Its Hydrus Microstent
Sight Sciences Says It Obtained $34 Million Patent Infringement Verdict Against Alcon -- Shares Jump
Sight Sciences (SGHT) said Monday it has received a jury trial verdict of $34 million related to the patent-infringement case it filed in September 2021 against Alcon (ALC) in the US District Court fo
Express News | Sight Sciences Announces $34M Patent Infringement Verdict Against Alcon And Its Hydrus Microstent For Microinvasive Glaucoma Surgery; Monetary Damages Comprised Of $5.5M In Lost Profits And $28.5M In Royalty Damages For Sales Of The Hydrus Microstent For
Express News | Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and Its Hydrus Microstent for Microinvasive Glaucoma Surgery
Comments
Baird advocates medtech companies such as Alcon, Stryker, and Cooper due to product and pricing strengths. Belief is strong in Alcon's 2024 margin possibilities, Stryker's premium pricing and predicted robust orthopedic demand, and projected revenue growth for Boston Scientific and Axonics.
Baird Names Top Medtech Picks for 2024; Bullish on Alcon, Axonics
Gapping up
$Rivian Automotive(RIVN.US$ +6% (The company reported a first-quarter loss that was narrower than expected. Rivian also said it's still on track to meet a 50,000-vehicle production target for 2023.)
$Celsius Holdings(CELH.US$ +11.1% (The company posted a strong earnings report. Celsius posted 40 cents in earnings per share for the first quarter, more than doubling the 19-cent consensus estimate of analysts polled by Str...
$Rivian Automotive(RIVN.US$ +6% (The company reported a first-quarter loss that was narrower than expected. Rivian also said it's still on track to meet a 50,000-vehicle production target for 2023.)
$Celsius Holdings(CELH.US$ +11.1% (The company posted a strong earnings report. Celsius posted 40 cents in earnings per share for the first quarter, more than doubling the 19-cent consensus estimate of analysts polled by Str...
11
Exact Sciences Price Target Raised to $85.00/Share From $55.00 by Craig-Hallum
$Exact Sciences(EXAS.US$ Price Target Raised to $85.00/Share From $55.00 by Craig-Hallum.
Baird Upgrades Alcon to Outperform, Raises Price Target to $90
Baird analyst Jeff Johnson upgrades $Alcon(ALC.US$ from Neutral to Outperform and raises the price target from $75 to $90.
BofA Securities Upgrades Celsius Holdings to Buy, Raises Price Target to $125
B o...
$Exact Sciences(EXAS.US$ Price Target Raised to $85.00/Share From $55.00 by Craig-Hallum.
Baird Upgrades Alcon to Outperform, Raises Price Target to $90
Baird analyst Jeff Johnson upgrades $Alcon(ALC.US$ from Neutral to Outperform and raises the price target from $75 to $90.
BofA Securities Upgrades Celsius Holdings to Buy, Raises Price Target to $125
B o...
15
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after the previous market closed (gaps range from large to small):
Gap Ups
1. $Unum Group(UNM.US$ - up 5.1%
2. $Generac(GNRC.US$ - up 5.0%
3. $Builders FirstSource(BLDR.US$ - up 4.9%
4. $Livent(LTHM.US$ - up 4.4%
5. $Pearson(PSO.US$ - up 4.1%
6. $Verisk Analytics(VRSK.US$ - up 3.6%
7. $Assurant(AIZ.US$ - up 2.7%
8. $Vodafone(VOD.US$ - up...
Gap Ups
1. $Unum Group(UNM.US$ - up 5.1%
2. $Generac(GNRC.US$ - up 5.0%
3. $Builders FirstSource(BLDR.US$ - up 4.9%
4. $Livent(LTHM.US$ - up 4.4%
5. $Pearson(PSO.US$ - up 4.1%
6. $Verisk Analytics(VRSK.US$ - up 3.6%
7. $Assurant(AIZ.US$ - up 2.7%
8. $Vodafone(VOD.US$ - up...
+16
15
2
Read more